Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an update.
WuXi AppTec Co., Ltd. recently held an extraordinary general meeting where key resolutions were passed, including the cancellation of the supervisory committee and amendments to the articles of association. The meeting saw participation from a significant number of shareholders, with 51.9894% of the total shares with voting rights represented, indicating strong shareholder engagement in the company’s governance matters.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$132.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical and biotechnology industry. The company is known for providing comprehensive laboratory and manufacturing services that enable pharmaceutical, biotech, and medical device companies to advance discoveries and deliver new treatments to patients.
Average Trading Volume: 9,160,998
Technical Sentiment Signal: Buy
Current Market Cap: HK$341.4B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.